Brian K Halak Insider Trading Transactions
Get free email notifications about insider trading for Brian K Halak.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Brian K Halak. Brian K Halak is Director in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM) and 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in CADENCE PHARMACEUTICALS INC ($CADX) and Director in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in Volcano Corp ($VOLC) and 10% Owner in ZOGENIX, INC. ($ZGNX) and 10% Owner in VERACYTE, INC. ($VCYT) and 10% Owner in Orexigen Therapeutics, Inc. ($OREX) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in Evoke Pharma Inc ($EVOK) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and 10% Owner in TANDEM DIABETES CARE INC ($TNDM) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in Durata Therapeutics, Inc. ($DRTX).
Latest Insider Trading Transactions of Brian K Halak
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ACHN, ALIM, CADX, CLVS, DRNA, DRTX, ESPR, EVOK, TZYM, OREX, TNDM, VNDA, VCYT, VOLC, ZGNX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2020 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 6.70 | 3,333 | 22,331 | 3,333 | |
Jun 21 2019 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 0.92 | 50,000 | 46,000 | 50,000 | |
Nov 06 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 14.16 | 11 | 156 | 19,150 | 19.2 K to 19.2 K (-0.06 %) |
Nov 06 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 14.16 | 1,489 | 21,084 | 2,586,535 | 2.6 M to 2.6 M (-0.06 %) |
Nov 06 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 13.18 | 761 | 10,030 | 19,161 | 19.9 K to 19.2 K (-3.82 %) |
Nov 06 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 13.18 | 102,067 | 1,345,243 | 2,588,024 | 2.7 M to 2.6 M (-3.79 %) |
Nov 06 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 12.98 | 295 | 3,829 | 19,922 | 20.2 K to 19.9 K (-1.46 %) |
Nov 06 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 12.98 | 39,606 | 514,086 | 2,690,091 | 2.7 M to 2.7 M (-1.45 %) |
Nov 06 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 13.47 | 1,412 | 19,020 | 20,217 | 21.6 K to 20.2 K (-6.53 %) |
Nov 06 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 13.47 | 189,359 | 2,550,666 | 2,729,697 | 2.9 M to 2.7 M (-6.49 %) |
Nov 01 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 13.37 | 1,408 | 18,825 | 21,629 | 23 K to 21.6 K (-6.11 %) |
Nov 01 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 13.37 | 188,167 | 2,515,793 | 2,919,056 | 3.1 M to 2.9 M (-6.06 %) |
Nov 01 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 13.60 | 959 | 13,042 | 23,037 | 24 K to 23 K (-4.00 %) |
Nov 01 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 13.60 | 128,670 | 1,749,912 | 3,107,923 | 3.2 M to 3.1 M (-3.98 %) |
Nov 01 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 14.31 | 678 | 9,702 | 23,996 | 24.7 K to 24 K (-2.75 %) |
Nov 01 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 14.31 | 90,918 | 1,301,037 | 3,236,593 | 3.3 M to 3.2 M (-2.73 %) |
Nov 01 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 13.68 | 1,136 | 15,540 | 24,674 | 25.8 K to 24.7 K (-4.40 %) |
Nov 01 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Sell | S | 13.68 | 152,364 | 2,084,340 | 3,327,511 | 3.5 M to 3.3 M (-4.38 %) |
Jun 25 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | A | 13.08 | 25,000 | 327,000 | 25,000 | |
Jun 21 2018 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 0.86 | 40,000 | 34,400 | 40,000 | |
Jun 11 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | M | 7.00 | 156 | 1,092 | 0 | |
Jun 11 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | M | 7.00 | 21,041 | 147,287 | 0 | |
Jun 11 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Payment of Exercise | F | 14.45 | 76 | 1,098 | 25,810 | 25.9 K to 25.8 K (-0.29 %) |
Jun 11 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Payment of Exercise | F | 14.45 | 10,195 | 147,318 | 3,479,875 | 3.5 M to 3.5 M (-0.29 %) |
Jun 11 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Buy | M | 7.00 | 156 | 1,092 | 25,886 | 25.7 K to 25.9 K (+0.61 %) |
Jun 11 2018 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Buy | M | 7.00 | 21,041 | 147,287 | 3,490,070 | 3.5 M to 3.5 M (+0.61 %) |
Jul 20 2017 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | A | 3.42 | 25,000 | 85,500 | 25,000 | |
Jun 26 2017 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 1.37 | 40,000 | 54,800 | 40,000 | |
Jun 27 2016 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 1.49 | 20,000 | 29,800 | 20,000 | |
Jun 16 2016 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | A | 3.26 | 15,000 | 48,900 | 15,000 | |
Jul 17 2015 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Buy | J | 0.00 | 1,692 | 0 | 1,692 | 0 to 1.7 K |
Jun 29 2015 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | A | 13.87 | 15,000 | 208,050 | 15,000 | |
Jun 25 2015 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 5.00 | 20,000 | 100,000 | 20,000 | |
Jun 20 2014 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | A | 18.73 | 15,000 | 280,950 | 15,000 | |
Apr 18 2014 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | A | 16.30 | 25,000 | 407,500 | 25,000 | |
Jun 10 2014 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 5.56 | 20,000 | 111,200 | 20,000 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | C | 7.00 | 156 | 1,092 | 156 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | C | 7.00 | 156 | 1,092 | 0 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | C | 0.00 | 9,469 | 0 | 0 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | C | 0.00 | 3,535 | 0 | 0 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | C | 7.00 | 21,041 | 147,287 | 21,041 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | C | 7.00 | 21,041 | 147,287 | 0 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | C | 0.00 | 1,276,243 | 0 | 0 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Option Exercise | C | 0.00 | 476,464 | 0 | 0 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Buy | C | 0.00 | 13,004 | 0 | 13,004 | 0 to 13 K |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | Halak Brian K | Director | Buy | C | 0.00 | 1,752,707 | 0 | 1,752,707 | 0 to 1.8 M |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Halak Brian K | 10% Owner | Sell | D | 14.00 | 27,500 | 385,000 | 0 | 27.5 K to 0 (-100.00 %) |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Halak Brian K | 10% Owner | Sell | D | 14.00 | 50,743 | 710,402 | 0 | 50.7 K to 0 (-100.00 %) |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Halak Brian K | 10% Owner | Sell | D | 14.00 | 2,972,678 | 41,617,492 | 0 | 3 M to 0 (-100.00 %) |
Mar 17 2014 | AKAO | Achaogen Inc | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 7,430 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 15,799 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 10,661 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 435,663 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 926,321 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 625,065 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | Halak Brian K | 10% Owner | Buy | C | 0.00 | 33,890 | 0 | 33,890 | 0 to 33.9 K |
Mar 17 2014 | AKAO | Achaogen Inc | Halak Brian K | 10% Owner | Buy | C | 0.00 | 1,987,049 | 0 | 1,987,049 | 0 to 2 M |
Nov 04 2013 | VCYT | VERACYTE, INC. | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 5,053 | 0 | 0 | |
Nov 04 2013 | VCYT | VERACYTE, INC. | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 680,972 | 0 | 0 | |
Nov 04 2013 | VCYT | VERACYTE, INC. | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 17,677 | 0 | 0 | |
Nov 04 2013 | VCYT | VERACYTE, INC. | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 2,382,322 | 0 | 0 | |
Nov 04 2013 | VCYT | VERACYTE, INC. | Halak Brian K | 10% Owner | Buy | C | 0.00 | 22,730 | 0 | 22,730 | 0 to 22.7 K |
Nov 04 2013 | VCYT | VERACYTE, INC. | Halak Brian K | 10% Owner | Buy | C | 0.00 | 3,063,294 | 0 | 3,063,294 | 0 to 3.1 M |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | J | 7.37 | 6,008 | 44,279 | 6,008 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | J | 4.40 | 10,068 | 44,299 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 38,941 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 9,378 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 6,071 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | J | 7.37 | 352,351 | 2,596,827 | 352,351 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | J | 4.40 | 590,403 | 2,597,773 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 2,283,114 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 549,833 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 356,111 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 54,390 | 0 | 54,390 | 0 to 54.4 K |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 3,189,058 | 0 | 3,189,058 | 0 to 3.2 M |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | J | 7.37 | 6,008 | 44,279 | 6,008 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | J | 4.40 | 10,068 | 44,299 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 38,941 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 9,378 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 6,071 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | J | 7.37 | 352,351 | 2,596,827 | 352,351 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | J | 4.40 | 590,403 | 2,597,773 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 2,283,114 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 549,833 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 356,111 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 54,390 | 0 | 54,390 | 0 to 54.4 K |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 3,189,058 | 0 | 3,189,058 | 0 to 3.2 M |
Jul 16 2013 | TZYM | Ocera Therapeutics ... | Halak Brian K | 10% Owner | Buy | P | 6.03 | 331,873 | 1,999,999 | 1,897,336 | 1.6 M to 1.9 M (+21.20 %) |
Jul 16 2013 | TZYM | Ocera Therapeutics ... | Halak Brian K | 10% Owner | Buy | P | 6.03 | 7,333 | 44,192 | 7,333 | 0 to 7.3 K |
Jul 16 2013 | TZYM | Ocera Therapeutics ... | Halak Brian K | 10% Owner | Buy | P | 6.03 | 988,285 | 5,955,801 | 988,285 | 0 to 988.3 K |
Sep 30 2013 | EVOK | Evoke Pharma Inc | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 19,006 | 0 | 0 | |
Sep 30 2013 | EVOK | Evoke Pharma Inc | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 1,114,327 | 0 | 0 | |
Sep 30 2013 | EVOK | Evoke Pharma Inc | Halak Brian K | 10% Owner | Buy | C | 0.00 | 19,006 | 0 | 19,006 | 0 to 19 K |
Sep 30 2013 | EVOK | Evoke Pharma Inc | Halak Brian K | 10% Owner | Buy | C | 0.00 | 1,114,327 | 0 | 1,114,327 | 0 to 1.1 M |
Jul 02 2013 | ESPR | Esperion Therapeut ... | Halak Brian K | 10% Owner | Option Exercise | J | 6.99 | 1,193 | 8,339 | 1,193 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | Halak Brian K | 10% Owner | Option Exercise | J | 1.00 | 8,346 | 8,346 | 0 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 30,462 | 0 | 0 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | Halak Brian K | 10% Owner | Option Exercise | J | 6.99 | 70,042 | 489,594 | 70,042 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | Halak Brian K | 10% Owner | Option Exercise | J | 1.00 | 489,320 | 489,320 | 0 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 1,786,012 | 0 | 0 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | Halak Brian K | 10% Owner | Buy | P | 14.00 | 4,791 | 67,074 | 35,253 | 30.5 K to 35.3 K (+15.73 %) |
Jul 02 2013 | ESPR | Esperion Therapeut ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 30,462 | 0 | 30,462 | 0 to 30.5 K |
Jul 02 2013 | ESPR | Esperion Therapeut ... | Halak Brian K | 10% Owner | Buy | P | 14.00 | 280,923 | 3,932,922 | 2,066,935 | 1.8 M to 2.1 M (+15.73 %) |
Jul 02 2013 | ESPR | Esperion Therapeut ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 1,786,012 | 0 | 1,786,012 | 0 to 1.8 M |
Jun 19 2013 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 5.39 | 20,000 | 107,800 | 20,000 | |
Feb 01 2013 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 1.85 | 12,500 | 23,125 | 12,500 | |
Jan 18 2013 | ACHN | ACHILLION PHARMACE ... | Halak Brian K | 10% Owner | Buy | J | 0.00 | 66,462 | 0 | 159,896 | 93.4 K to 159.9 K (+71.13 %) |
Jan 18 2013 | ACHN | ACHILLION PHARMACE ... | Halak Brian K | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 5,772,968 | 6.8 M to 5.8 M (-14.76 %) |
Jul 24 2012 | DRTX | Durata Therapeutic ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 16,529 | 0 | 0 | |
Jul 24 2012 | DRTX | Durata Therapeutic ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 2,227,596 | 0 | 0 | |
Jul 24 2012 | DRTX | Durata Therapeutic ... | Halak Brian K | 10% Owner | Buy | P | 9.00 | 5,777 | 51,993 | 22,306 | 16.5 K to 22.3 K (+34.95 %) |
Jul 24 2012 | DRTX | Durata Therapeutic ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 16,529 | 0 | 16,529 | 0 to 16.5 K |
Jul 24 2012 | DRTX | Durata Therapeutic ... | Halak Brian K | 10% Owner | Buy | P | 9.00 | 778,536 | 7,006,824 | 3,006,132 | 2.2 M to 3 M (+34.95 %) |
Jul 24 2012 | DRTX | Durata Therapeutic ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 2,227,596 | 0 | 2,227,596 | 0 to 2.2 M |
Jun 15 2012 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 2.77 | 7,500 | 20,775 | 7,500 | |
Jun 04 2012 | ACHN | ACHILLION PHARMACE ... | Halak Brian K | 10% Owner | Buy | J | 0.00 | 93,434 | 0 | 93,434 | 0 to 93.4 K |
Jun 04 2012 | ACHN | ACHILLION PHARMACE ... | Halak Brian K | 10% Owner | Sell | J | 0.00 | 1,200,000 | 0 | 6,772,968 | 8 M to 6.8 M (-15.05 %) |
Dec 22 2011 | OREX | Orexigen Therapeut ... | Halak Brian K | 10% Owner | Option Exercise | P | 0.00 | 7,882 | 8 | 7,882 | |
Dec 22 2011 | OREX | Orexigen Therapeut ... | Halak Brian K | 10% Owner | Option Exercise | P | 0.00 | 461,265 | 461 | 461,265 | |
Dec 22 2011 | OREX | Orexigen Therapeut ... | Halak Brian K | 10% Owner | Buy | P | 1.45 | 7,882 | 11,429 | 50,643 | 42.8 K to 50.6 K (+18.43 %) |
Dec 22 2011 | OREX | Orexigen Therapeut ... | Halak Brian K | 10% Owner | Buy | P | 1.45 | 461,265 | 668,834 | 2,967,415 | 2.5 M to 3 M (+18.41 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 43,809 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 2,568,521 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | P | 13.00 | 15,625 | 203,125 | 51,013 | 35.4 K to 51 K (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 6,324 | 0 | 35,388 | 29.1 K to 35.4 K (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 15,106 | 0 | 29,064 | 14 K to 29.1 K (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 13,958 | 7 K to 14 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 6,979 | 0 to 7 K |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | P | 13.00 | 916,058 | 11,908,754 | 2,990,937 | 2.1 M to 3 M (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 370,799 | 0 | 2,074,879 | 1.7 M to 2.1 M (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 885,696 | 0 | 1,704,080 | 818.4 K to 1.7 M (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 818,384 | 409.2 K to 818.4 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 409,192 | 0 to 409.2 K |
Sep 20 2011 | ZGNX | ZOGENIX, INC. | Halak Brian K | 10% Owner | Buy | P | 2.00 | 58,696 | 117,392 | 169,251 | 110.6 K to 169.3 K (+53.09 %) |
Sep 20 2011 | ZGNX | ZOGENIX, INC. | Halak Brian K | 10% Owner | Buy | P | 2.00 | 3,441,304 | 6,882,608 | 9,923,335 | 6.5 M to 9.9 M (+53.09 %) |
Jun 09 2011 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 7.53 | 7,500 | 56,475 | 7,500 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 14,903 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 21,027 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 35,215 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 873,800 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 1,232,861 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 2,064,781 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | Halak Brian K | 10% Owner | Buy | P | 4.00 | 39,410 | 157,640 | 110,555 | 71.1 K to 110.6 K (+55.39 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | Halak Brian K | 10% Owner | Buy | C | 0.00 | 14,903 | 0 | 71,145 | 56.2 K to 71.1 K (+26.50 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | Halak Brian K | 10% Owner | Buy | C | 0.00 | 21,027 | 0 | 56,242 | 35.2 K to 56.2 K (+59.71 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | Halak Brian K | 10% Owner | Buy | C | 0.00 | 35,215 | 0 | 35,215 | 0 to 35.2 K |